- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07709039
"Comparison of of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes in Laparoscopic Cholecystectomy" (VCV VS PCV)
"Comparison of the Effects of Volume-Controlled Ventilation and Pressure-Controlled Ventilation Modes on Compliance and End-Tidal CO2 In Patients Undergoing Laparoscopic Cholecystectomy"
Study Overview
Status
Intervention / Treatment
Detailed Description
Laparoscopic cholecystectomy is one of the most commonly performed surgical procedures under general anesthesia. Creation of carbon dioxide pneumoperitoneum during laparoscopic surgery increases intra-abdominal pressure, resulting in reduced functional residual capacity, decreased lung compliance, increased airway pressures, and alterations in carbon dioxide elimination. These physiological changes may impair respiratory mechanics and increase the risk of perioperative pulmonary complications. Therefore, selection of an appropriate mechanical ventilation strategy is essential to maintain adequate ventilation and optimize respiratory function during laparoscopic surgery. The objective of this randomized controlled trial is to compare the effects of volume-controlled ventilation and pressure-controlled ventilation on static lung compliance and end-tidal carbon dioxide (EtCO₂) in adult patients undergoing elective laparoscopic cholecystectomy under general anesthesia. The study aims to determine whether pressure-controlled ventilation provides superior intraoperative respiratory mechanics compared with volume-controlled ventilation while maintaining adequate ventilation throughout the surgical procedure.
This is a prospective, single-center, randomized controlled trial conducted in the Department of Anaesthesia, Nishtar Hospital, Multan. A total of 60 adult patients aged 25-50 years, of either sex, classified as American Society of Anesthesiologists (ASA) physical status I or II and scheduled for elective laparoscopic cholecystectomy, will be enrolled after obtaining written informed consent. Patients with uncontrolled cardiopulmonary disease, diabetes mellitus, significant renal or hepatic impairment, chronic systemic illness, body mass index below 18.5 kg/m² or above 24.9 kg/m², or recent respiratory tract infection within the preceding three weeks will be excluded.
Participants will be allocated in a 1:1 ratio using computer-generated randomization by an independent third party into one of two study groups. Group A will receive volume-controlled ventilation, while Group B will receive pressure-controlled ventilation. Allocation concealment will be maintained until initiation of mechanical ventilation. Baseline demographic variables including age, sex, and body mass index will be recorded before induction of anesthesia.
A standardized anesthetic technique will be used for all participants. Mechanical ventilation settings will include a tidal volume of 8 mL/kg (with inspiratory pressure adjusted in the PCV group to achieve the target tidal volume), respiratory rate initially set at 12 breaths per minute and subsequently adjusted to maintain an end-tidal carbon dioxide concentration between 32 and 38 mmHg, inspiratory-to-expiratory ratio of 1:2, fraction of inspired oxygen (FiO₂) of 0.40, positive end-expiratory pressure (PEEP) of 5 cmH₂O, and oxygen saturation maintained above 95%. Carbon dioxide pneumoperitoneum will be maintained with an intra-abdominal pressure of 12-15 mmHg throughout the procedure.
Static lung compliance and end-tidal carbon dioxide will be recorded at three predefined intraoperative time points: five minutes after induction of anesthesia, fifteen minutes after carbon dioxide insufflation in the reverse Trendelenburg position, and ten minutes after carbon dioxide desufflation. Measurements will be recorded using the integrated monitoring systems of the anesthesia workstation by a trained anesthesiologist who is not involved in group allocation. Blinding of the anesthesia provider is not feasible because of the nature of the interventions; however, the primary outcome measures are objective monitor-derived variables, minimizing the risk of measurement bias.
The primary outcome measures are static lung compliance and end-tidal carbon dioxide measured at the predefined intraoperative time points. Data will be analyzed using SPSS version 26. Continuous variables will be summarized as mean ± standard deviation or median with interquartile range according to data distribution, while categorical variables will be expressed as frequencies and percentages. Between-group comparisons will be performed using the independent t-test or Mann-Whitney U test as appropriate, with stratification for age, sex, and body mass index where indicated.
This study is expected to provide evidence regarding the optimal ventilation strategy during laparoscopic cholecystectomy and may contribute to improved intraoperative respiratory management and enhanced patient safety in routine anesthetic practice.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab Province
-
Multan, Punjab Province, Pakistan, 00000
- Nishtar Medical University and Hospital, Multan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients aged 25-50 years.
- Either sex.
- ASA physical status I or II.
- Scheduled for elective laparoscopic cholecystectomy under general anaesthesia.
- Written informed consent obtained.
Exclusion Criteria:
- ASA physical status III or IV.
- Body mass index (BMI) greater than 35 kg/m².
- Significant pulmonary disease (e.g., COPD, asthma, restrictive lung disease).
- Significant cardiovascular disease.
- Pregnancy.
- Previous upper abdominal surgery.
- Conversion to open cholecystectomy.
- Refusal to participate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Volume Controlled Ventilation
Participants receive volume-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia.
|
Mechanical ventilation delivered using the volume-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia.
Ventilation is provided with a tidal volume of 8 mL/kg, respiratory rate adjusted to maintain end-tidal carbon dioxide between 32 and 38 mmHg, PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure.
|
|
Experimental: Pressure Controlled Ventilation
Participants receive pressure-controlled ventilation during elective laparoscopic cholecystectomy under general anesthesia.
|
Mechanical ventilation delivered using the pressure-controlled ventilation mode during elective laparoscopic cholecystectomy under general anesthesia.
Inspiratory pressure is adjusted to achieve a tidal volume of 8 mL/kg while maintaining end-tidal carbon dioxide between 32 and 38 mmHg, with PEEP of 5 cmH₂O, FiO₂ of 0.40, and an inspiratory-to-expiratory ratio of 1:2 throughout the surgical procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Static Lung Compliance
Time Frame: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Comparison of static lung compliance between the volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) groups during elective laparoscopic cholecystectomy under general anesthesia.
|
Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
|
End-Tidal Carbon Dioxide (EtCO₂)
Time Frame: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Comparison of end-tidal carbon dioxide (EtCO₂) levels between the VCV and PCV groups.
|
Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Inspiratory Pressure
Time Frame: Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Comparison of peak inspiratory pressure between the VCV and PCV groups during laparoscopic cholecystectomy.
|
Measured at three intraoperative time points: 5 minutes after induction of anesthesia, 15 minutes after carbon dioxide pneumoperitoneum in the reverse Trendelenburg position, and 10 minutes after carbon dioxide desufflation.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18717 / NMU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Cholecystectomy
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
Clinical Research Centre, MalaysiaCompletedComplication Laparoscopic Cholecystectomy | Conversion Laparoscopic to Open CholecystectomyMalaysia
-
Intuitive SurgicalCompletedLaparoscopic Cholecystectomy | Robotic-assisted CholecystectomyUnited States
-
Gangnam Severance HospitalRecruitingCholecystectomy, Laparoscopic | Cholecystectomy, RoboticSouth Korea
-
Assiut UniversityNot yet recruiting
-
IHU StrasbourgScialytics SASRecruitingCholecystectomy, LaparoscopicFrance
-
Assiut UniversityNot yet recruiting
-
Mohamed Bakr Mohamed AhmedNot yet recruitingLaparoscopic Cholecystectomy
-
Istanbul University - CerrahpasaActive, not recruitingCholecystectomy, LaparoscopicTurkey (Türkiye)
-
Ulas AdayCompletedLaparoscopic CholecystectomyTurkey (Türkiye)
Clinical Trials on Volume-Controlled Ventilation
-
Beni-Suef UniversityRecruitingVentilation Therapy; ComplicationsEgypt
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityUnknown
-
Cantonal Hospital of St. GallenNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications (PPCs)Switzerland
-
Istanbul UniversityUnknown
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownPostoperative Respiratory ComplicationKorea, Republic of
-
Ankara Etlik City HospitalCompletedPositive Pressure VentilationTurkey (Türkiye)
-
Derince Training and Research HospitalCompletedLaparoscopic SurgeriesTurkey
-
Ain Shams UniversityCompletedPostoperative Pulmonary DysfunctionEgypt
-
Yonsei UniversityCompletedGeneral AnesthesiaKorea, Republic of
-
Antalya Training and Research HospitalCompleted